Share this article

Dental devices include products used for diagnosis of dental ailments and for dental treatment such as oral prophylaxis, dental surgical and restorative procedures. Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease, or developmental deficiency. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dbgs and regenerative materials market in New Zealand. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the dbgs and regenerative materials market in New Zealand was Dentium followed by Dentsply Sirona, Geistlich Pharma, LifeNet Health, Straumann and Zimmer Biomet.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Bone grafts and regenerative materials regenerate the natural bone and dental tissue. Dental bone graft substitutes include dental bone grafts and synthetic dental bone graft substitutes. Synthetic dental bone graft substitutes are used for the treatment of a dental bone defect.

The dbgs and regenerative materials market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size dbgs and regenerative materials in New Zealand, buy the report here.

This content was updated on 29 November 2023

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.